• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过限制酶抑制法评估铂类放射增敏剂复合物与DNA的结合

Assessment of DNA binding of platinum-radiosensitizer complexes by inhibition of restriction enzymes.

作者信息

Skov K A, Adomat H, Konway D C, Farrell N P

出版信息

Chem Biol Interact. 1987;62(2):117-29. doi: 10.1016/0009-2797(87)90084-6.

DOI:10.1016/0009-2797(87)90084-6
PMID:3036382
Abstract

A simple and rapid method has been used to compare the binding of platinum complexes to DNA, in a relatively qualitative manner. A compound bound at or near the restriction site inhibits enzymatic cleavage of DNA; inhibition of BamHI and EcoRI activity by complexes was assessed in this study using linearized pSV2-gpt plasmid. Our particular interest was in DNA binding by complexes of platinum (Pt) with known organic radiosensitizers (RS), to determine whether the Pt was able to target the RS to the DNA. Although the Pt-RS complexes investigated themselves have moderate radiosensitizing ability (like the inorganic complexes, cis- or trans-diamminedichloroplatinum(II), c- or t-DDP) none of the Pt-RS inhibit to the same extent as c- or t-DDP. However, there appears to be some correlation between enhanced radiosensitization by Pt-RS over Pt(RS)2, with the degree of Pt binding (as assessed by our assay). Our results using isolated DNA suggest that not all complexes bind well (e.g. Pt with two RS ligands), but that in certain cases (e.g. Pt with only one RS), it is possible to target the drug to the DNA. An ammine or amine ligand may be required in order to target a radiosensitizer to DNA using platinum.

摘要

一种简单快速的方法已被用于以相对定性的方式比较铂配合物与DNA的结合。在限制位点或其附近结合的化合物会抑制DNA的酶切;本研究中使用线性化的pSV2 - gpt质粒评估了配合物对BamHI和EcoRI活性的抑制作用。我们特别感兴趣的是铂(Pt)与已知有机放射增敏剂(RS)的配合物与DNA的结合,以确定Pt是否能够将RS靶向到DNA上。尽管所研究的Pt - RS配合物本身具有中等放射增敏能力(如无机配合物顺式或反式二氯二氨铂(II),c - 或t - DDP),但没有一种Pt - RS的抑制程度与c - 或t - DDP相同。然而,Pt - RS相对于Pt(RS)2增强的放射增敏作用与Pt的结合程度(通过我们的测定评估)之间似乎存在一些相关性。我们使用分离DNA的结果表明,并非所有配合物都能很好地结合(例如带有两个RS配体的Pt),但在某些情况下(例如仅带有一个RS的Pt),有可能将药物靶向到DNA上。为了使用铂将放射增敏剂靶向到DNA上,可能需要一个氨或胺配体。

相似文献

1
Assessment of DNA binding of platinum-radiosensitizer complexes by inhibition of restriction enzymes.通过限制酶抑制法评估铂类放射增敏剂复合物与DNA的结合
Chem Biol Interact. 1987;62(2):117-29. doi: 10.1016/0009-2797(87)90084-6.
2
Binding mode of 2-amino-5-nitrothiazole (ANT) in platinum complexes, trans-[PtCl2(ANT)2], affects DNA binding, toxicity and radiosensitizing ability.2-氨基-5-硝基噻唑(ANT)在铂配合物反式-[PtCl2(ANT)2]中的结合模式会影响DNA结合、毒性和放射增敏能力。
Int J Radiat Biol Relat Stud Phys Chem Med. 1987 Aug;52(2):289-97. doi: 10.1080/09553008714551751.
3
Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).针对经顺式或反式二氯二氨铂(II)修饰的DNA的单克隆抗体。
Proc Natl Acad Sci U S A. 1987 Dec;84(23):8225-9. doi: 10.1073/pnas.84.23.8225.
4
Restriction-enzyme cleavage of DNA modified by platinum(II) complexes.经铂(II)配合物修饰的DNA的限制性内切酶切割
Eur J Biochem. 1993 Aug 15;216(1):183-7. doi: 10.1111/j.1432-1033.1993.tb18131.x.
5
Modification of the recognition of restriction sites of plasmid DNA by the antitumor drug Pt-pentamidine.抗肿瘤药物铂-喷他脒对质粒DNA限制性酶切位点识别的修饰作用
Biochem Pharmacol. 1996 Sep 27;52(6):851-6. doi: 10.1016/0006-2952(96)00351-6.
6
Cleavage by restriction enzymes of DNA modified with the antitumour drug cis-diamminedichloroplatinum(II).用抗肿瘤药物顺二氨二氯铂(II)修饰的DNA经限制性内切酶切割
Gen Physiol Biophys. 1992 Dec;11(6):579-88.
7
Characterization of the reactions of platinum antitumor agents with biologic and nonbiologic sulfur-containing nucleophiles.铂类抗肿瘤药物与生物及非生物含硫亲核试剂反应的表征
Biochem Pharmacol. 1987 Jun 15;36(12):1955-64. doi: 10.1016/0006-2952(87)90494-1.
8
Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).轴向配体和脂环大小调节氨/环烷基胺-铂(IV)配合物在对顺二氯二氨铂(II)或反式-1R,2R-1S,2S-二氨基环己烷四氯铂(IV)耐药的肿瘤细胞中的活性和生化药理学。
Cancer Res. 1994 Sep 1;54(17):4691-7.
9
Different binding to DNA of enantiomeric platinum complexes assessed by inhibition of restriction enzyme activity.通过限制酶活性抑制评估对映体铂配合物与DNA的不同结合
Anticancer Res. 1989 May-Jun;9(3):795-8.
10
The berenil ligand directs the DNA binding of the cytotoxic drug Pt-berenil.
J Inorg Biochem. 1997 Dec;68(4):283-7. doi: 10.1016/s0162-0134(97)00111-6.

引用本文的文献

1
Immunocytochemical labelling of aerobic and hypoxic mammalian cells using a platinated derivative of EF5.使用EF5的铂化衍生物对需氧和缺氧哺乳动物细胞进行免疫细胞化学标记。
Br J Cancer Suppl. 1996 Jul;27:S200-3.